Icht O - Search Results

1

Arterial and Venous Thromboembolism in ALK-Rearrangement-Positive Non-small Cell Lung Cancer: A Population-Based Cohort Study.

Icht O, Leader A, Batat E, Yosef L, Shochat T, Goldstein DA, Dudnik E, Spectre G, Raanani P, Hammerman A, Zer A. Icht O, et al. Oncologist. 2023 Jun 2;28(6):e391-e396. doi: 10.1093/oncolo/oyad061. Oncologist. 2023. PMID: 37014824 Free PMC article.

2

Treatment beyond progression with immune checkpoint inhibitors in non-small-cell lung cancer.

Reinhorn D, Jacobi O, Icht O, Dudnik E, Rotem O, Zer A, Goldstein DA. Reinhorn D, et al. Among authors: icht o. Immunotherapy. 2020 Mar;12(4):235-243. doi: 10.2217/imt-2019-0131. Epub 2020 Mar 19. Immunotherapy. 2020. PMID: 32189549

3

Lower tumor volume is associated with increased benefit from immune checkpoint inhibitors in patients with advanced non-small-cell lung cancer.

Icht O, Domachevsky L, Groshar D, Dudnik E, Rotem O, Allen AM, Peled N, Reinhorn D, Jacobi O, Shochat T, Bernstine H, Zer A. Icht O, et al. Asia Pac J Clin Oncol. 2021 Apr;17(2):e125-e131. doi: 10.1111/ajco.13360. Epub 2020 Aug 6. Asia Pac J Clin Oncol. 2021. PMID: 32762128

4

Intracranial hemorrhage with direct oral anticoagulants in patients with brain metastases.

Leader A, Hamulyák EN, Carney BJ, Avrahami M, Knip JJ, Rozenblatt S, Beenen LFM, Yust-Katz S, Icht O, Coppens M, Raanani P, Middeldorp S, Büller HR, Zwicker JI, Spectre G. Leader A, et al. Among authors: icht o. Blood Adv. 2020 Dec 22;4(24):6291-6297. doi: 10.1182/bloodadvances.2020003238. Blood Adv. 2020. PMID: 33351124 Free PMC article.

5

Sarcoma incidence and subtype distribution in Israel - A population-based study.

Icht O, Lewin R, Yosef L, Fichman S, Silverman B, Zer A. Icht O, et al. Cancer Epidemiol. 2021 Feb;70:101876. doi: 10.1016/j.canep.2020.101876. Epub 2020 Dec 24. Cancer Epidemiol. 2021. PMID: 33352525

6

Venous thromboembolism incidence and risk assessment in lung cancer patients treated with immune checkpoint inhibitors.

Icht O, Darzi N, Shimony S, Jacobi O, Reinhorn D, Landman Y, Mutai R, Averbuch I, Shochat T, Spectre G, Raanani P, Rotem O, Dudnik E, Peled N, Zer A, Leader A. Icht O, et al. J Thromb Haemost. 2021 May;19(5):1250-1258. doi: 10.1111/jth.15272. Epub 2021 Mar 16. J Thromb Haemost. 2021. PMID: 33605020 Free article.

7

Bevacizumab for stereotactic radiosurgery-induced radiation necrosis in patients with non-small cell lung cancer treated with immune check-point inhibitors.

Moore A, Yust-Katz S, Icht O, Eliyahou R, Gordon N, Cohen AY, Goldstein IM, Peled N, Seigal T, Amiel A, Dudnik E. Moore A, et al. Among authors: icht o. J Neurol Sci. 2021 Aug 15;427:117556. doi: 10.1016/j.jns.2021.117556. Epub 2021 Jun 24. J Neurol Sci. 2021. PMID: 34186494

8

The Relationship of Diabetes Mellitus to Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer.

Jacobi O, Landman Y, Reinhorn D, Icht O, Sternschuss M, Rotem O, Finkel I, Allen AM, Dudnik E, Goldstein DA, Zer A. Jacobi O, et al. Among authors: icht o. Oncology. 2021;99(9):555-561. doi: 10.1159/000516671. Epub 2021 Jul 9. Oncology. 2021. PMID: 34247166

9

[No title available]

[No authors listed] [No authors listed] PMID: 34701981

10

Phase II single-arm study of nivolumab and ipilimumab (Nivo/Ipi) in previously treated classical Kaposi sarcoma (cKS).

Zer A, Icht O, Yosef L, Avram D, Jacobi O, Fenig E, Kurman N, Peretz I, Shamai S, Merimsky O, Ben-Ami E, Shapira Frommer R, Schwarzbach AE, Bernstine H, Weitzen R, Vornicova O, Bar-Sela G, Stemmer SM, Lotem M. Zer A, et al. Among authors: icht o. Ann Oncol. 2022 Jul;33(7):720-727. doi: 10.1016/j.annonc.2022.03.012. Epub 2022 Mar 23. Ann Oncol. 2022. PMID: 35339649 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page